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INFECTIOUS AND IMMUNE SYNERGISTIC FACTORS IN TISSUE INJURY.
PARALLELS BETWEEN CHRONIC OBSTRUCTIVE RESPIRATORY DISEASE
AND CHRONIC PYELONEPHRITIS**
Attempts to produce in animals disease equivalent to the chronic obstruc-
tive airway disease of man have met with little success. Experimental ap-
proaches have usually focussed on single etiological mechanisms, e.g. chronic
hypoxia, chronic inflammation, or antigen-antibody reactions.' Such studies,
by deliberate design, have excluded multiple or synergistic factors acting
in concert.
Infection or, more specifically, infectious bronchitis is widely believed to
be a major factor in the obstructive respiratory disease syndrome and the
acute exacerbations which punctuate its course.t' Yet in our studies of this
disease, lower respiratory tract secretions collected during acute exacerba-
tions by transtracheal or laryngeal puncture have proved to be bacteriologi-
cally sterile in one third of our patients and to contain no demonstrable
viral agent.84 Therefore, infectious factors were not of vital significance in
this group of patients, at least during the time that they were studied.
In this presentation I wish to make two points. First, I want to highlight
some of the analogies that exist between chronic obstructive respiratory
disease and another clinical enigma, chronic pyelonephritis. Second, based
on our studies of experimental pyelonephritis I wish to underline the im-
portance of infectious and immune factors in tissue injury and to suggest
that both may be critical factors in devising model systems of chronic ob-
structive respiratory disease.
Analogies between chronic lung disease and chronic pyelonephritis
As indicated in Table 1, both the lung and the kidney are "extracor-
poreal" organ systems. Each is in continual contact with the outside bac-
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tute of Allergy and Infectious Diseases, and Training Grant AM 05069-12 from the
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t Factors other than infection may well be of additional major importance. Emphy-
sema is not invariably accompanied by chronic bronchitis and all cases of chronic
bronchitis are not associated with emphysema. Yet in the bulk of patients with chronic
obstructive airway disease, infectious bronchitis is a common finding. It is this large
group of patients that the author has in mind in preparing this discussion.
550Infectious andimmune synergistic factors A
TABLE 1. ANALOGIES BETWEEN OBSTRUCTIVE RESPiRATORY DISEASE
AND CHRONIC PYELONEPHRITIS
1. Lung and kidney represent "extracorporeal" systems.
2. Both possess organ-specific antigens and anti-organ antibodies are demonstrable in
association with occurrence of either disease.
3. Chronic progressive diseases punctuated by acute exacerbations.
a. Pathogenic bacteria may be present in sputum or urine.
b. Sputum or urine may be sterile.
4. Tissue specimens may be sterile.
5. Ill-defined histologic endpoint; absence of identifying pathological hallmark.
teria-laden world and periodic infection is a common occurrence. Both the
lung and the kidney possess organ-specific antigenic constituents."-7 Anti-
bodies reactive with lung or sputum have been reported in patients with
chronic pulmonary disease.8" Antibodies directed against kidney have also
been demonstrated in animals and man with renal disease.lOU
Both diseases (Table 1) follow a progressive course interrupted by
acute exacerbations. Some of these exacerbations are associated with patho-
genic bacteria in the sputum or urine. In other exacerbations, even in the
same patient, cultures of the sputum or urine may be sterile." Lung or
kidney tissue, secured by biopsy or at autopsy, may also prove to be free of
bacteria.
Finally, in neither chronic obstructive respiratory disease nor chronic
pyelonephritis is there a pathologic hallmark identifying one pathogenetic
mechanism over another. Histologic changes considered characteristic of
each disease may be induced by a variety of mechanisms. For example,
morphologic features of pyelonephritis may be induced by infection or
vascular occlusion or obstruction to urine flow."8' Even "thyroidization"
may not be a unique and invariable microscopic finding associated with in-
fection of the kidney. The same situation exists with respect to the lung,
changes of chronic obstructive lung disease having been produced by such
different procedures as capillary obliteration and prolonged, repeated ex-
posure to sulfur dioxide."1" Indeed, in both chronic lung disease and
pyelonephritis, diagnosis usually rests on demonstrated physiologic mal-
functions in contrast to physical or anatomic abnormalities.
Experimental pyelonephritis in rats
Pyelonephritis has been under study in our laboratories using a model
system of rats infected with staphylococci.18 In our work we have focussed
on excretion of beta-glucuronidase in the urine as a means of monitoring
renal cell injury."7'8 A major stimulus for this experimental approach was
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the report that measurement of urinary beta-glucuronidase might be a
promising means for detection of chronic pyelonephritis in man.'9 Rat renal
tubule cells contain large amounts of this enzyme as well as other hydrolytic
enzymes. Damage to these cells, either by staphylococcal infection or mer-
cury, results in increased excretion of beta-glucuronidase in the urine."'T"
Experimental staphylococcal pyelonephritis in rats is associated with
increased urinary excretion of beta-glucuronidase. Two patterns of enzyme
excretion are observed. In some rats, illustrated in Figure 1, beta-glu-
curonidase excretion rises precipitously about four days after staphylococcal
infection, remains elevated for two or three days, returns to normal pre-
infection levels and stays at pre-infection levels. Rise in enzyme is accom-
panied by intense pyuria and heavy bacteriuria. Rats sacrificed at this
point have viable staphylococci in their kidneys. Fall in enzyme is associated
with disappearance of pyuria and little or no bacteriuria. Rats sacrificed at
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FIG. 1. Monophasic pattern of urinary beta-glucuronidase excretion in rats with
experimental staphylococcal pyelonephritis. The amount of urine enzyme liberating
one microgram of phenolphthalein from a phenolphthalein monoglucuronide substrate
per hour of incubation at 380 C. under defined conditions was termed one unit.tr En-
zyme activity per hour of urine collection expressed as units per collection hour.
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FIG. 2. Biphasic pattern of urinary beta-glucurqnidase excretion in rats with experi-
mental staphylococcal pyelonephritis. Definition of enzyme activity and units per col-
lection hour as set out in legend for Figure 1.
this point, i.e. 12-20 days after infection, may have sterile kidneys. This
monophasic glucuronidase excretion pattern reflects transitory infection of
the kidneys, clearing of bacteria, recovery and cessation of renal cell injury.
A second pattern of enzyme excretion is illustrated in Figure 2. Urine
beta-glucuronidase excretion again rises rapidly, reaches peak values by
the 4th day after infection and returns toward baseline values by the 8th
day. Initial rise in enzyme again is associated with appearance of pyuria
and bacteriuria. Fall in enzyme to baseline values is associated with dis-
appearance of pyuria.* About two weeks after infection, a second rise and
fall in urine glucuronidase occurs. This second wave in enzyme excretion
is not associated sith pyuria. In some animals, urine and kidneys contain
no viable staphylococci.
* Accurate information about viable bacteria in urine requires culture of urine ob-
tained by bladder puncture at time animals are sacrificed. Since rats represented by
data in Figure 2 were not sacrificed until 20 or more days post-infection, precise in-
formation regarding presence and number of viable staphylococci in urine at the time
initially elevated enzyme values returned to baseline, i.e. 8-12 days, is not available.
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Based on preliminary data obtained from our studies, two lines of evi-
dence suggest that the second enzyme excretion peak in some animals may
represent continued or recurrent renal injury having an immunologic
rather than an infectious basis. First, cyclophosphamide, a potent immuno-
logic suppressive agent, in a dose known to abolish both circulating anti-
body and cell-mediated immune responses, diminishes the second enzyme
excretion peak. Second, work in progress suggests that transfer of lymphoid
cells from donor rats sensitized to staphylococci into recipients that have
recovered from staphylococcal pyelonephritis elicits a prompt increased
excretion of urinary beta-glucuronidase.
Postulated synergistic effects of infectious and immune factors
in tissue injury
These observations suggest that pyelonephritis in its subacute or chronic
forms involves both infectious factors and immune responses which act in
concert to induce and/or perpetuate kidney damage.
The sequence of events we visualize taking place in the kidney is shown
schematically in Figure 3. Normal renal tubule cells actively infected with
viable bacteria are injured. Antigen deposition by dead and dying bacteria
inside of tubule cells or on their surface takes place as the infected host
RENAL TUBULE CELLS
ACTIVE INFECTION: VIABLE BACTERIA
.ANTIGEN DEPOSITIONs DEAD BACTERIA
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ADDITIONAL CELL INJURY
FIG. 3. Postulated sequence of infectious and immunologic events leading to renal
cell injury.
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eliminates viable bacteria. Local and/or systemic immune responses against
the infecting bacteria result in antigen-"sensitized cell" interactions at sites
of antigen deposition. Further inflammation and additional cell injury oc-
curs. Persisting viable bacteria might well set off subsequent waves of in-
fection and elicit additional cycles of antigen-immune response interaction.
With time, progressive impairment in renal function would lead to clinical
manifestations of chronic pyelonephritis at which time the urine and, in-
deed, the kidney itself, might well contain no viable bacteria.
The sequence of events in Figure 3 is equivalent biologically to rejection
by a host of his own (autologous) kidney. It is of interest that one type of
renal transplant rejection pattern observed by the Paris group simulates
chronic pyelonephritis histologically and is so-classified.' The production
of a localized graft-versus-host reaction in the kidney, induced by sub-
capsular injection of allogeneic lymphocytes, gives rise to an inflammatory
reaction with a striking resemblance to pyelonephritis.' This latter finding
by Elkins' plus evidence that circulating antibodies against gram-negative
bacillary antigens may decrease, rather than increase, incidence or severity
of experimental pyelonephritis in rats," and our own strong interests in
cell-mediated immune responses, explain why "sensitized cells" or "sen-
sitized lymphocytes" rather than conventional antibody is selected as the
type of immune response of importance in the events set out in Figure 3.
If one substituted bronchial epithelial cells for renal tubule cells in Figure
3, the events depicted might well culminate in chronic bronchial cell injury
and inflammation, resistance to air outflow and the physiologic-anatomic
consequences which collectively comprise the chronic obstructive respira-
tory syndrome. The theory is amenable to test; essential materials are at
hand.
SUMMARY
In this brief and speculative discussion, analogies between chronic ob-
structive respiratory disease and chronic pyelonephritis have been examnined
and observations concerning experimental pyelonephritis in rats presented.
A picture of infectious and immune factors acting in concert to perpetuate
cell injury emerges. The concepts may prove useful in devising better ex-
perimental animal model systems of obstructive airway disease, desirable
and much needed tools in attacking the problem of chronic lung disease
of man.
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